Carmat SA (EPA:ALCAR)

France · Delayed Price · Currency is EUR

0.0990

0.00 (0.00%)

Inactive · Last trade price on Mar 20, 2026

Market Cap	6.15M -87.3%
Revenue (ttm)	7.34M +91.4%
Net Income	-51.40M
EPS	-1.15
Shares Out	62.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0990
Day's Range	n/a
52-Week Range	0.0850 - 0.9500
Beta	1.02
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 8, 2026

About Carmat

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2008

Employees 153

Stock Exchange Euronext Paris

Ticker Symbol ALCAR

Full Company Profile

Financial Performance

In 2024, Carmat's revenue was 7.34 million, an increase of 91.40% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.59% less than in 2023.

Financial Statements